Related Experiment Videos
[Simultaneous incidence of bronchial asthma and polyarteritis nodosa (Wilson-Alexander syndrome)]
Orvosi Hetilap
|August 11, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution.
Clinical and translational radiation oncology·2024
Benign Brenner tumour of the ovary: CT and MRI features.
Clinical radiology·2021
Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2020
[Atypical cutaneous manifestations of B19 parvovirus infection in children].
Orvosi hetilap·2026
[Premature mortality attributable to preventable risk factors in Hungary].
Orvosi hetilap·2026
[Psychological and clinical aspects of breast implants].
Orvosi hetilap·2026
Temporal associations of BMI transition with metabolic inflammation in allergic rhinitis: A retrospective cohort study.
The World Allergy Organization journal·2026
A Prospective Observational Real-World Study to Assess the Effectiveness and Safety of Single-Inhaler Triple Therapy with Glycopyrrolate/Formoterol Fumarate/Budesonide in Patients with Uncontrolled Asthma.
The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Mouse blood protein survives degradation in Ixodes ricinus ticks after moulting and starvation for up to five months.
Ticks and tick-borne diseases·2026
Successful Treatment of Refractory Pemphigus Vulgaris with Ultra-Low-Dose Rituximab in a High-Risk Patient: A Case Report.
Clinical, cosmetic and investigational dermatology·2026